SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-21-047558
Filing Date
2021-09-13
Accepted
2021-09-13 08:00:41
Documents
15
Period of Report
2021-09-10
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea147272-8k_inmedpharma.htm   iXBRL 8-K 44220
2 PRESS RELEASE, DATED SEPTEMBER 13, 2021 ea147272ex99-1_inmedpharma.htm EX-99.1 20367
3 GRAPHIC ex99-1_001.jpg GRAPHIC 5348
  Complete submission text file 0001213900-21-047558.txt   280540

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE inm-20210910.xsd EX-101.SCH 3030
5 XBRL DEFINITION FILE inm-20210910_def.xml EX-101.DEF 26194
6 XBRL LABEL FILE inm-20210910_lab.xml EX-101.LAB 34239
7 XBRL PRESENTATION FILE inm-20210910_pre.xml EX-101.PRE 22363
8 EXTRACTED XBRL INSTANCE DOCUMENT ea147272-8k_inmedpharma_htm.xml XML 3629
Mailing Address SUITE 310, 815 W. HASTINGS STREET VANCOUVER A1 V6C 1B4
Business Address SUITE 310, 815 W. HASTINGS STREET VANCOUVER A1 V6C 1B4 (604) 669-7207
InMed Pharmaceuticals Inc. (Filer) CIK: 0001728328 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-39685 | Film No.: 211248645
SIC: 2834 Pharmaceutical Preparations